<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39244203</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-5843</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Sep</Month><Day>07</Day></PubDate></JournalIssue><Title>Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists</Title><ISOAbbreviation>Arch Clin Neuropsychol</ISOAbbreviation></Journal><ArticleTitle>How Mild Is the Mild Long COVID? A Comprehensive Neuropsychological Assessment of Patients with Cognitive Complaints.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">acae071</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/arclin/acae071</ELocationID><Abstract><AbstractText>The global impact of the Coronavirus Disease (COVID-19) pandemic has extended beyond physical health, leading to widespread mental health issues. Beyond respiratory symptoms, there is a growing concern about long-term cognitive effects, particularly in individuals who experienced mild cases of the infection. We aimed to investigate the neuropsychological aspects of long-term COVID-19 in non-hospitalized adults compared with a control group. This cross-sectional study included 42 participants, 22 individuals with a history of mild COVID, and 20 healthy controls. The participants were recruited from the community and underwent a comprehensive neuropsychological assessment. Participants from the mild COVID group reported cognitive symptoms persisting for an average of 203.86&#xa0;days and presented a higher frequency of psychological treatment history (81.8%) compared with the control group (25.0%). History of anxiety disorders was more prevalent in the mild COVID group (63.6%) than in the control group (20.0%). Significant reductions in verbal working memory were observed in the mild COVID group. Levels of anxiety were found to have a significant impact on difficulties with visual recognition memory. This study reveals important neuropsychological alterations in individuals following mild COVID-19, emphasizing executive functions deficits. Our findings underscore the persistence of these deficits even in non-hospitalized cases, suggesting potential inflammatory mechanisms in the central nervous system. The study highlights the need for comprehensive assessments and targeted interventions to address the diverse cognitive impacts on individuals recovering from COVID-19.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lopes-Santos</LastName><ForeName>Lucas Emmanuel</ForeName><Initials>LE</Initials><Identifier Source="ORCID">0000-0003-4016-5806</Identifier><AffiliationInfo><Affiliation>Department of Medical Imaging, Hematology, and Clinical Oncology, Ribeir&#xe3;o Preto Medical School, University of S&#xe3;o Paulo, Ribeir&#xe3;o Preto, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Lacerda Ferreira</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medical Imaging, Hematology, and Clinical Oncology, Ribeir&#xe3;o Preto Medical School, University of S&#xe3;o Paulo, Ribeir&#xe3;o Preto, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Angelis</LastName><ForeName>Geisa</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical Imaging, Hematology, and Clinical Oncology, Ribeir&#xe3;o Preto Medical School, University of S&#xe3;o Paulo, Ribeir&#xe3;o Preto, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foss</LastName><ForeName>Maria Paula</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Neurosciences and Behavioral Sciences, Ribeir&#xe3;o Preto Medical School, University of S&#xe3;o Paulo, Ribeir&#xe3;o Preto, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trevisan</LastName><ForeName>Ana Carolina</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Medical Imaging, Hematology, and Clinical Oncology, Ribeir&#xe3;o Preto Medical School, University of S&#xe3;o Paulo, Ribeir&#xe3;o Preto, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Lacerda</LastName><ForeName>Kleython Jos&#xe9; Coriolano Cavalcanti</ForeName><Initials>KJCC</Initials><AffiliationInfo><Affiliation>Department of Medical Imaging, Hematology, and Clinical Oncology, Ribeir&#xe3;o Preto Medical School, University of S&#xe3;o Paulo, Ribeir&#xe3;o Preto, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tumas</LastName><ForeName>Vitor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neurosciences and Behavioral Sciences, Ribeir&#xe3;o Preto Medical School, University of S&#xe3;o Paulo, Ribeir&#xe3;o Preto, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellissimo-Rodrigues</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Social Medicine, Ribeir&#xe3;o Preto Medical School, University of S&#xe3;o Paulo, Ribeir&#xe3;o Preto, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wichert-Ana</LastName><ForeName>Lauro</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medical Imaging, Hematology, and Clinical Oncology, Ribeir&#xe3;o Preto Medical School, University of S&#xe3;o Paulo, Ribeir&#xe3;o Preto, SP, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2021/12671-3</GrantID><Agency>S&#xe3;o Paulo Research Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arch Clin Neuropsychol</MedlineTA><NlmUniqueID>9004255</NlmUniqueID><ISSNLinking>0887-6177</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cognitive deficits</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Mild COVID</Keyword><Keyword MajorTopicYN="N">Neuropsychological assessment</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>8</Day><Hour>13</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>8</Day><Hour>13</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>7</Day><Hour>20</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39244203</ArticleId><ArticleId IdType="doi">10.1093/arclin/acae071</ArticleId><ArticleId IdType="pii">7750687</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>